Valdecoxib
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Product Specifications
CAS Number
181695-72-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
314.36
Molecular Formula
C16H14N2O3S
Notes
Research use only, not for human use.
Receptor
COX-2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PT_74005-01 5 µg
Glyoxalase Domain Containing 4 Human Recombinant (GLOD4 Human)
Sign In for Pricing
View Details PT_74005-02 20 µg
Glyoxalase Domain Containing 4 Human Recombinant (GLOD4 Human)
Sign In for Pricing
View Details PT_74005-03 1 mg
Glyoxalase Domain Containing 4 Human Recombinant (GLOD4 Human)
Sign In for Pricing
View Details